Back
Citius Pharmaceuticals Stock Price Chart
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!
Sell
15
CTXR
Citius Pharmaceuticals
Last Price:
0.52
Seasonality Move:
-5.4%
7 Day Trial
ALL ACCESS PASS
$
7
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.53 | Sell |
| 20-day SMA: | 0.53 | Sell |
| 50-day SMA: | 0.67 | Sell |
| 200-day SMA: | 0.71 | Sell |
| 8-day EMA: | 0.53 | Sell |
| 20-day EMA: | 0.55 | Sell |
| 50-day EMA: | 0.61 | Sell |
| 200-day EMA: | 0.72 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 40.78 | Sell |
| Chaikin Money Flow: | 21586 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.51 - 0.59) | Sell |
| Bollinger Bands (100): | (0.54 - 0.8) | Sell |
Citius Pharmaceuticals Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.52 while CTXR 8-day simple moving average is 0.53, which is a Sell signal.
- The stock price of CTXR is 0.52 while Citius Pharmaceuticals 20-day SMA is 0.53, which makes it a Sell.
- Citius Pharmaceuticals 50-day simple moving average is 0.67 while CTXR share price is 0.52, making it a Sell technically.
- CTXR stock price is 0.52 and Citius Pharmaceuticals 200-day simple moving average is 0.71, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
15
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a Sell
The current Citius Pharmaceuticals [CTXR] share price is $0.52. The Score for CTXR is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
94.32M
Price in USD:
0.52
Share Volume:
759.43K
Citius Pharmaceuticals 52-Week Range
52-Week High:
1.07
52-Week Low:
0.48
Sell
15
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?
The Citius Pharmaceuticals stock price is 0.52 USD today. -
Will CTXR stock go up or go down?
Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Citius Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.52 while CTXR 8-day exponential moving average is 0.53, which is a Sell signal.
- The stock price of CTXR is 0.52 while Citius Pharmaceuticals 20-day EMA is 0.55, which makes it a Sell.
- Citius Pharmaceuticals 50-day exponential moving average is 0.61 while CTXR share price is 0.52, making it a Sell technically.
- CTXR stock price is 0.52 and Citius Pharmaceuticals 200-day simple moving average is 0.72, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.10 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
- CTXR Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Citius Pharmaceuticals is a Sell
- Citius Pharmaceuticals Relative Strength Index (RSI) is 40.78, which suggest Citius Pharmaceuticals is oversold
- The Bollinger Bands (25) for Citius Pharmaceuticals is (0.51 - 0.59), which suggest Citius Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Citius Pharmaceuticals is (0.54 - 0.8), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.